StockWatch
·
Other Consumer Services
RegulatoryNov 20, 2026, 06:45 PM

MEDIROM Regains Nasdaq Periodic Filing Compliance; Bid Price Deficiency Remains

AI Summary

MEDIROM Healthcare Technologies Inc. announced it has regained compliance with Nasdaq's periodic filing requirement after filing its Form 20-F for the year ended December 31, 2025. Nasdaq has closed the matter related to the delayed filing. However, the company still needs to address a separate deficiency regarding the minimum bid price by April 5, 2027. MEDIROM operates wellness salons under the "Re.Ra.Ku®" brand and has expanded into HealthTech with apps and a smart tracker.

Key Highlights

  • MEDIROM regained compliance with Nasdaq's periodic filing requirement.
  • The company filed its Form 20-F for the year ended December 31, 2025.
  • Nasdaq has closed the matter of the delayed annual report filing.
  • MEDIROM still faces a minimum bid price deficiency under Nasdaq Listing Rule 5550(a)(2).
  • The company has until April 5, 2027, to regain compliance with the bid price requirement.